Abstract
The global prevalence of diabetes is still on the rise and has reached 573 million individuals. This population has cardiovascular mortality twice that observed in patients without diabetes, and risk of up to 30% of developing diabetic sensorimotor neuropathy (DSPN). DSPN shares pathophysiologic mechanisms related to the progression of atherosclerotic disease. Therefore, it is possible th…